Promoting Ethical Payment in Human Infection Challenge Studies

The right to withdraw from controlled human infection studies: Justifications and avoidance

(2020) Holly Fernandez Lynch   BIOETHICS

Economic vulnerability and payment for research participation

(2020) Luke Gelinas et al.   Clinical Trials

Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials

(2020) Soumya J. Niranjan et al.   CANCER

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure

(2020) Nir Eyal et al.   JOURNAL OF INFECTIOUS DISEASES

Paying Participants in COVID-19 Trials

(2020) Emily A Largent et al.   JOURNAL OF INFECTIOUS DISEASES

Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy

(2020) Euzebiusz Jamrozik et al.   JOURNAL OF MEDICAL ETHICS

Compensation and hazard pay for key workers during an epidemic: an argument from analogy

(2020) Doug McConnell et al.   JOURNAL OF MEDICAL ETHICS

Ethics of controlled human infection to address COVID-19

(2020) Seema K. Shah et al.   SCIENCE

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study

(2020) Irene Jao et al.   BIOETHICS

Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation

(2020) D. Gbesemete et al.   BMC Medicine

Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development

(2020) Linh Chi Nguyen et al.   CLINICAL INFECTIOUS DISEASES

Persistent Symptoms in Patients After Acute COVID-19

(2020) Angelo Carfì et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon

(2020) Liza Dawson et al.   JOURNAL OF INFECTIOUS DISEASES

Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials

(2020) Marie-Astrid Hoogerwerf et al.   BMJ Open

SARS-CoV-2 challenge studies: ethics and risk minimisation

(2020) Susan Bull et al.   JOURNAL OF MEDICAL ETHICS

Payment in challenge studies: ethics, attitudes and a new payment for risk model

(2020) Olivia Grimwade et al.   JOURNAL OF MEDICAL ETHICS

Early approval of a COVID-19 vaccine could stymie the hunt for better ones

(2020) Jon Cohen   SCIENCE

Differential payment to research participants in the same study: an ethical analysis

(2019) Govind Persad et al.   JOURNAL OF MEDICAL ETHICS

Compensation for cures: Why we should pay a premium for participation in ‘challenge studies’

(2019) Jonathan Anomaly et al.   BIOETHICS

Picking and Choosing Among Phase I Trials

(2019) Jill A. Fisher et al.   Journal of Bioethical Inquiry

Disparate compensation policies for research related injury in an era of multinational trials: a case study of Brazil, Russia, India, China and South Africa

(2018) George Rugare Chingarande et al.   BMC Medical Ethics

Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation

(2018) Matt Lamkin et al.   JOURNAL OF LAW MEDICINE & ETHICS

A Framework for Ethical Payment to Research Participants

(2018) Luke Gelinas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bystander risk, social value, and ethics of human research

(2018) S. K. Shah et al.   SCIENCE

Addressing Financial Barriers to Enrollment in Clinical Trials

(2018) Emily A. Largent et al.   JAMA Oncology

Making the case for completion bonuses in clinical trials

(2018) Emily A Largent et al.   Clinical Trials

Exploring Ethical Concerns About Human Challenge Studies: A Qualitative Study of Controlled Human Malaria Infection Study Participants’ Motivations and Attitudes

(2018) Stephanie A. Kraft et al.   Journal of Empirical Research on Human Research Ethics

Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study

(2018) Jill A. Fisher et al.   PLOS MEDICINE

Lessons from HeLa Cells: The Ethics and Policy of Biospecimens

(2016) Laura M. Beskow   Annual Review of Genomics and Human Genetics

Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program

(2016) Ryan D. Nipp et al.   ONCOLOGIST

Patient Income Level and Cancer Clinical Trial Participation

(2016) Joseph M. Unger et al.   JAMA Oncology

Risks of phase I research with healthy participants: A systematic review

(2015) Rebecca A Johnson et al.   Clinical Trials

Ethical Criteria for Human Challenge Studies in Infectious Diseases: Table 1.

(2015) Ben Bambery et al.   Public Health Ethics

Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: Enhancing minority participation in clinical trials (EMPaCT)

(2014) Raegan W. Durant et al.   CANCER

More than the money: A review of the literature examining healthy volunteer motivations

(2010) Leanne Stunkel et al.   Contemporary Clinical Trials

Informative inducement: Study payment as a signal of risk

(2009) Cynthia E. Cryder et al.   SOCIAL SCIENCE & MEDICINE

Do Incentives Exert Undue Influence on Survey Participation? Experimental Evidence

(2008) Eleanor Singer et al.   Journal of Empirical Research on Human Research Ethics